MS center ErasMS

MS center ErasMS provides complex patient care, but also contributes to research and education on multiple sclerosis and other demyelinating diseases of the CNS

[touchNEUROLOGY @touchNEUROLOGY]

@drruthdobson (UK) and @SmetsIde (The Netherlands) explore the practicalities of therapeutic sequencing options in MS.

Watch now: https://t.co/KBGQa0QtrE

#MedTwitter #Neurology #NeuroImmunology #MS #MultipleSclerosis #MedEd

[MS center ErasMS @ErasMS_Rdam]

AHSCT for MS now available in the Netherlands for pwMS not responding to high efficacy therapies! nohttps://www.linkedin.com/posts/erasmus-mc-ms-center-erasms_stamceltransplantatie-voor-specifieke-groep-activity-7009461245594468352-uVty?utm_source=share&utm_medium=member_android

[MS center ErasMS @ErasMS_Rdam]

https://t.co/Eu5XrhPnzK

[Ide Smets @SmetsIde]

In simulated MS cohorts, lesion detection algorithms argue to be disease-modifying by detection more lesions, triggering early treatment switches and preventing disability. Nice feature or necessary add-on intervention?
https://t.co/bALFi2FIXr

[Ide Smets @SmetsIde]

Rituximab (anti-CD20) is a more potent MS drug than dimethyl fumarate. The bigger question: is it better than the more costly ocrelizumab? Three possible answers: an official, a real and a right one. Which one do you prefer?@the_MSBlog https://t.co/juIWL45eWi

[MS center ErasMS @ErasMS_Rdam]

Een nieuwe generatie MS behandeling komt eraan, maar hoe werken deze BTK-remmers eigenlijk? Team #ErasMS zocht het uit. Zie: https://t.co/1883QupUOq

[MS center ErasMS @ErasMS_Rdam]

Multiple sclerose onderzoekers kunnen zich tot 11 september 2022 aanmelden als kandidaat voor de Rogier Hintzen Talent Award 2022! Zie voor meer info https://t.co/1883QupUOq

[Ide Smets @SmetsIde]

There’s no exit strategy for pwMS on anti-CD20 atm. Some argue there’s no need to exit, some argue to extend intervals and we argue to stop anti-CD20 after 4 infusion cycli. Do you agree? https://t.co/Jk4WLLv3sI @ErasMS_Rdam

[MS center ErasMS @ErasMS_Rdam]

Yes, reached the summit of Mont Ventoux with @MoveS_MS, team #ErasMS and team #NHB! Touched and inspired by the stories of all participants with and without #MS and proud of the team. Back to work now! Joost@ErasMS

[MS center ErasMS @ErasMS_Rdam]

Team ErasMS is going to drive 1000km in an old VW to climb Mont Ventoux next weekend to raise money for #MultipleSclerosis research. Please support us at https://t.co/Cgi11clYQR! Read the post of Joost@ErasMS at https://t.co/qyut3RtbSS

[ECTRIMS @ECTRIMS]

The deadline to submit your abstract for #ECTRIMS2022 is just around the corner. Use this week to complete your research, submit your innovative work & become part of an outstanding scientific programme.

⏱️ Deadline: 18 May 2022

Apply today ➡️ https://t.co/lGKf30155I

[MS center ErasMS @ErasMS_Rdam]

When soccer meets MS! Attending the Dutch Neurology Association meeting on MS with great talks on RIS (Kees Okkersen, Jeroen van Eijk), digital biomarkers (Ka-hoo Lam) and MS mimics (Judith van Everdingen).

[MS center ErasMS @ErasMS_Rdam]

Donate to Stichting Klimmen tegen MS https://t.co/SM69l0Eio7
#Team #ErasMS will join all dedicated participants in the climbing of Mont Ventoux with Stichting MOVES to raise money for MS research. Do you support us and the MS community?

[MS center ErasMS @ErasMS_Rdam]

Team MS center #ErasMS wishes you health and happiness in the new year! https://t.co/2cLyS9dT9T

[MS center ErasMS @ErasMS_Rdam]

Team #ErasMS excited to open the online MS research days 2021! Great program empowering the Dutch MS research community with @MS_Research, @MScentrum020, @Hersenbank, MS centrum Noord Nederland, Nieuw Unicum, Hasselt and many others!

[MS center ErasMS @ErasMS_Rdam]

REGEN-COV is beschikbaar voor patiënten van #Erasms met hoog risico op afwezige antistoffen na COVID-19 vaccinatie én een ernstig COVID-19 verloop. Check voor details https://t.co/PPGR5LbqJw

[MS center ErasMS @ErasMS_Rdam]

Just visited with the lab of team #Erasms the spectacular new depot @boijmans in front of our hospital #erasmusmc @rotterdam. Highly recommended!

[MS center ErasMS @ErasMS_Rdam]

The Dordrecht city run was cancelled due to COVID-19, but team ErasMS ran 10km to support the SPIN-P study on primary progressive MS! https://t.co/dkW9ByArOi #multiplesclerosis

[MS center ErasMS @ErasMS_Rdam]

Team #ErasMS looks back to a great ISNI 2021 meeting! We contributed to the online program, and look forward to live scientific interaction with our collegues! #ISNI2021 #weareneuroimmunology #erasms https://t.co/2cLyS9dT9T

[MS center ErasMS @ErasMS_Rdam]

Waarom die bloemkool? Bijgedragen aan het inspirerende contextprogramma bij de voorstelling Zenuwslopend van Ilse Oostvogels @Parktheater. Deze voorstelling is een aanrader voor iedereen met interesse in MS, zie: https://t.co/7Iy5azBUzu. #erasms https://t.co/2cLyS9dT9T